Visiomed Group SA
PAR:ALVMG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Visiomed Group SA
Depreciation & Amortization
Visiomed Group SA
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Visiomed Group SA
PAR:ALVMG
|
Depreciation & Amortization
€3.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
32%
|
CAGR 10-Years
15%
|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Depreciation & Amortization
€3.4m
|
CAGR 3-Years
21%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
|
|
Biomerieux SA
PAR:BIM
|
Depreciation & Amortization
€438.4m
|
CAGR 3-Years
87%
|
CAGR 5-Years
16%
|
CAGR 10-Years
14%
|
|
|
S
|
SMAIO SA
PAR:ALSMA
|
Depreciation & Amortization
€1.3m
|
CAGR 3-Years
10%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Depreciation & Amortization
€13.6m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Mauna Kea Technologies SA
PAR:ALMKT
|
Depreciation & Amortization
€1.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
6%
|
|
Visiomed Group SA
Glance View
Visiomed Group SA engages in the development and distribution of healthcare products and services. The company is headquartered in Puteaux, Ile-De-France. The company went IPO on 2011-07-05. The firm is primarily engaged in the design, manufacture and marketing of medical electronics. The company develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The firm's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The firm serves pharmacies, health professionals, hospitals, clinics and retirement homes. The company also offers connected solutions and COVID devices such as deconfinement kits, masks, filter cushion, serological tests etc. The Company’s subsidiaries include ThermoFlash and BewellConnect.
See Also
What is Visiomed Group SA's Depreciation & Amortization?
Depreciation & Amortization
3.1m
EUR
Based on the financial report for Dec 31, 2023, Visiomed Group SA's Depreciation & Amortization amounts to 3.1m EUR.
What is Visiomed Group SA's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
15%
Over the last year, the Depreciation & Amortization growth was 14%.
